M&A in pharma

Explores the merits of mega-deal in contrast to a more measured portfolio growth strategy

Therapeutic

Our wide range of market research reports on the thriving Therapeutic sector of Healthcare provides detailed analyses on all types of disease markets and techniques. These reports are designed to assist clients in their key decisions regarding competitive advantages and threats.

Title	Publication Date	Price
World Market for Addiction Disorders, 2009 - 2016, The Future Therapies for Substance Dependence and Impulse Control The report estimates that the current market for addiction disorders is valued at US$3.2 billion and this is forecast to increase 19% to US$3.8 billion by 2016.	October 2009	£1,495
Cancer Market Trends 2008 - 2012 Key market forecasts and growth opportunities (update) Updated, comprehensive report delivers accurate market figures and forecasts on the global cancer drug market. Contains profiles of top pharmaceutical companies in this sector.	January 2009	£1,100
Cardiovascular Pharmaceutical Market Trends, 2007 to 2010 Key market forecasts and growth opportunities Market forecasts on the global market for cardiovascular drug treatments and companies	August 2007	£895
CNS Market Trends, 2007 to 2010 Key Market Forecasts and Growth Opportunities Market forecasts on the global market for CNS drug treatments and companies	June 2007	£995
Preclinical Cancer Therapeutics 2007 Decoding Next Generation Drug Targets for Market Success	December 2006	£1,600
Global Market for Antimicrobials and Antifungals; The Challenging Resistance to 2016	December 2006	£1,600
Chemotherapy Market Insights, 2006-2016 A Critical Analysis of Cancer Research, Treatments, Pipelines, and Commercial Opportunities	April 2006	£1,900
Antiageing and Life Enhancement Pharmacotherapeutics	January 2006	£795
Global Market for Sleep-Wake Disorders, 2005-2012, The Trends, Opportunities, and Insights in a High-Value CNS Therapy Area	December 2005	£795
Psychopharmacotherapy Market Insights Obstacles & Opportunities in Mood Disorders & Cognitive Impairment, 2005-2012 Examines the global mood disorder sector and highlights the converging market stimulators and inhibitors that may lead to a market decline from an estimated US$17.4 billion in 2005 to US$15 billion in 2012	November 2005	£795